GMZ2-Aluminum Hydroxide

GMZ2 · European Vaccine Initiative

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMZ2-Aluminum Hydroxide, covering 2007-08-10 to 2007-08-10. Get the full timeline:

Most recent: Clinical Trial Update: GMZ2-Aluminum Hydroxide Phase I, Tübingen [Phase 1]